Rep. Glenn Grothman @RepGrothman
Monoclonal antibodies have been a resounding success in treating #COVID19. Notably, President Trump used them when he contracted the virus. The fact that this treatment isn’t widely available is yet another shortcoming of @POTUS during his first year in office. @RepublicanStudy https://t.co/lDRqH4NkuP — PolitiTweet.org